Mohamed Elbaiomy

6PUBLICATIONS
19CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 02, 2023
The prognostic values of the IL-10 (G1082A) and TNF-α (G308A) polymorphisms in Egyptian patients with acute lymphoblastic leukemia: A single-center study.

Mohamed A El Baiomy, Tamer Akl, Nadia ElMenshawy

|Oct 17, 2022
Molecular Mechanisms Mediating Ceftazidime/Avibactam Resistance Amongst Carbapenem-Resistant Klebsiella pneumoniae Isolates from Cancer Patients.

Rania Abd El-Hamid El-Kady, Mohamed Ali Elbaiomy, Rasha Mokhtar Elnagar

|Nov 02, 2021
Suggested Modifications to the Management of Patients With Breast Cancer During the COVID-19 Pandemic: Web-Based Survey Study.

Shereef Elsamany, Mohamed Elbaiomy, Ahmed Zeeneldin

|Jul 21, 2020
Clinical Impact of Breast Cancer Stem Cells in Metastatic Breast Cancer Patients.

M A Elbaiomy, Tamer Akl, Nadia Atwan

|Apr 16, 2020
Thrombophilic Risk of Factor V Leiden, Prothrombin G20210A, MTHFR, and Calreticulin Mutations in Essential Thrombocythemia Egyptian Patients.

Mohamed S El-Ghonemy, Solafa El Sharawy, Maryan Waheeb Fahmi

|Jan 14, 2020
Prognostic Impact of Lymphoid Enhancer Factor 1 Expression and Serum Galectin.3 in Egyptian AML Patients.

M A ElBaiomy, S Aref, M El Zaafarany

Pageof 1

Frequent Collaborators

2 joint publications

Mohamed S El-Ghonemy

1 joint publications

S Aref

1 joint publications

Tamer Akl

1 joint publications

Nadia ElMenshawy